ArticleBioImpacts : BI2025

Targeting hypoxia-inducible factor 1 alpha augments synergistic effects of chemo/immunotherapy via modulating tumor microenvironment in a breast cancer mouse model.

Mohsen Rashid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.